We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

Back to rankings

18 hedge funds and large institutions have $37.4M invested in BioAmber Inc. in 2013 Q2 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
–
Reduced
–
Closed
–
Calls
$1.04M
Puts
–
Net Calls
+$1.04M
Net Calls Change
+$1.04M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$19M +$20.8M +2,794,810 New
ACPU
2
Arrowgrass Capital Partners (US)
Delaware
$5.14M +$5.62M +755,400 New
PRCM
3
Pine River Capital Management
Minnesota
$3.65M +$4M +537,500 New
MCM
4
Moore Capital Management
New York
$2.06M +$2.25M +302,500 New
CS
5
Credit Suisse
Switzerland
$1.39M +$1.52M +205,051 New
LCS
6
Levin Capital Strategies
New York
$1.12M +$1.23M +165,000 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$986K +$1.08M +145,000 New
Millennium Management
8
Millennium Management
New York
$918K +$1M +135,000 New
SCM
9
Saba Capital Management
New York
$867K +$948K +127,450 New
JGC
10
J. Goldman & Co
New York
$863K +$944K +126,900 New
UOC
11
UBS O'Connor
Illinois
$680K +$744K +100,000 New
Deutsche Bank
12
Deutsche Bank
Germany
$306K +$335K +45,000 New
NIMI
13
Natixis Investment Managers International
France
$267K +$238K +32,000 New
Goldman Sachs
14
Goldman Sachs
New York
$158K +$172K +23,200 New
TRCT
15
Tower Research Capital (TRC)
New York
$12K +$12.6K +1,700 New
Barclays
16
Barclays
United Kingdom
$9K +$9.96K +1,339 New
BIT
17
BlackRock Institutional Trust
California
$4K +$4.2K +565 New
U
18
UBS
Switzerland
$3K +$3.29K +442 New

BIOA Hedge Fund Activity: Q2 2013 in Review

18 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q2 2013, worth a combined $37.4M.

Buyers outnumbered sellers: 18 funds opened new BIOA positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

  • 18 institutional investors held BioAmber Inc. (BIOA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $37.4M of BioAmber Inc. stock for Q2 2013.
  • 18 funds opened new BioAmber Inc. positions in Q2 2013 and 0 closed out, a net change of +18 holders.

Based on aggregated 13F filings for Q2 2013.